Respiratory Distress Syndrome, Adult
114
3
4
65
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
12 trials with published results (11%)
Research Maturity
65 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
15.8%
18 terminated out of 114 trials
78.3%
-8.2% vs benchmark
11%
13 trials in Phase 3/4
18%
12 of 65 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 65 completed trials
Clinical Trials (114)
A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS
Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome
Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in Emergency Department
Reproductibility of TM-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in the ER
Trial of Therapeutic Hypothermia in Patients With ARDS
Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome
Pre-hospital Ventilation Clinical Study
Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma
The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Randomized Controlled Trial
Long Term Follow up of Children Enrolled in the REDvent Study
Effect of Implementing Sleep Care Bundle on Nurses' Practice and Patients' Outcomes
Ventilation and Perfusion in the Respiratory System
Early Use of Prone Position in ECMO for Severe ARDS
High Flow Nasal Oxygen for Acute Hypoxemic Respiratory Failure in the Emergency Room
Can Novel Oxygenation Indices Guide the Diagnosis of Acute Respiratory Distress Syndrome
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms
Utility of Defining ARDS and Past and Current Definitions of ARDS
Identifying PARDS Endotypes
Multi-drug Resistant Gram-negative Bacteria and Veno-venous Extracorporeal Membrane Oxygenation (ECMO)
Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome